We are live on ! Find out more
IC

IEQ Capital Portfolio holdings

AUM $21.5B
1-Year Est. Return 75.26%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
+$644M
Cap. Flow
+$171M
Cap. Flow %
3.45%
Top 10 Hldgs %
37.64%
Holding
981
New
89
Increased
388
Reduced
336
Closed
81

Top Buys

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$47.1M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$47M
3
RBLX icon
Roblox
RBLX
+$27.7M
4
JOBY icon
Joby Aviation
JOBY
+$15.4M
5
AAPL icon
Apple
AAPL
+$12.3M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$12.8M
2
CRWD icon
CrowdStrike
CRWD
+$9.9M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$7.59M
4
SLAB icon
Silicon Laboratories
SLAB
+$7.54M
5
PEN icon
Penumbra
PEN
+$7.08M

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Communication Services 13.07%
3 Consumer Discretionary 6.86%
4 Healthcare 6.72%
5 Financials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALP
876
Alpha Compute
ALP
$4.62M
$58.2K ﹤0.01%
+833
New +$55.5K
BLND icon
877
Blend Labs
BLND
$431M
$51.4K ﹤0.01%
54,239
– –
ONCT
878
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$49.8K ﹤0.01%
7,222
– –
BBD icon
879
Banco Bradesco
BBD
$39.3B
$49.6K ﹤0.01%
14,329
+3,422
+31% +$10.6K
SABA
880
Saba Capital Income & Opportunities Fund II
SABA
$220M
$49.1K ﹤0.01%
+5,934
New +$49.9K
MOVE icon
881
Corvex Inc
MOVE
$299M
$46K ﹤0.01%
382
– –
PRE icon
882
Prenetics Global
PRE
$317M
$43K ﹤0.01%
3,219
– –
PSNL icon
883
Personalis
PSNL
$1.35B
$41.4K ﹤0.01%
22,000
– –
GMDA
884
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$38.6K ﹤0.01%
+20,000
New +$34.4K
ALPS
885
DELISTED
Alpine Summit Energy Partners
ALPS
$33.2K ﹤0.01%
55,284
– –
HYFM icon
886
Hydrofarm Holdings
HYFM
$2.57M
$31.7K ﹤0.01%
4,054
– –
LYG icon
887
Lloyds Banking Group
LYG
$89.5B
$30.7K ﹤0.01%
13,941
+3,765
+37% +$8.63K
CIG icon
888
CEMIG Preferred Shares
CIG
$6.26B
$29.7K ﹤0.01%
+14,681
New +$27.5K
DNA icon
889
Ginkgo Bioworks
DNA
$528M
$29.3K ﹤0.01%
393
– –
DHY
890
Credit Suisse High Yield Credit Fund
DHY
$242M
$21.1K ﹤0.01%
+11,179
New +$21.2K
PGEN icon
891
Precigen
PGEN
$2.24B
$19K ﹤0.01%
16,528
– –
CGEN icon
892
Compugen
CGEN
$222M
$11.4K ﹤0.01%
+10,000
New +$8.71K
PDYN icon
893
Palladyne AI
PDYN
$247M
$9.64K ﹤0.01%
5,000
– –
WE
894
DELISTED
WeWork Inc.
WE
$7.66K ﹤0.01%
+750
New +$10.4K
NKTR icon
895
Nektar Therapeutics
NKTR
$2.39B
$6.67K ﹤0.01%
773
– –
AMTI
896
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$6.45K ﹤0.01%
25,000
– –
BZFD icon
897
BuzzFeed
BZFD
$99M
$5.68K ﹤0.01%
2,813
– –
NRXP icon
898
NRX Pharmaceuticals
NRXP
$135M
$4.83K ﹤0.01%
+1,000
New +$6.01K
IDEX
899
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$790 ﹤0.01%
85
– –
AAP icon
900
Advance Auto Parts
AAP
$3.35B
– –
-3,884
Closed -$472K
34 35
36
37 38

Similar funds

Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
AM
AGF Management Toronto, Ontario, Canada $22.3B AUM 46.42% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return

IEQ Capital's Q2 2023 Portfolio in Review

As of Q2 2023, IEQ Capital held 981 positions worth $4.96B, up 15% from $4.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

IEQ Capital deployed $171M of net new capital in Q2 2023, opening 89 new positions and adding to 388 existing holdings. Its largest new stake was Neurocrine Biosciences: 481,268 shares worth $45.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Salesforce, an estimated $12.8M trimmed.

  • IEQ Capital's largest Q2 2023 buy was Neurocrine Biosciences: 481,268 shares worth $45.4M.
  • IEQ Capital added most to Upbound Group in Q2 2023, an estimated $47.1M increase.
  • IEQ Capital's biggest Q2 2023 reduction was Salesforce, cutting an estimated $12.8M.
  • IEQ Capital fully exited Penumbra in Q2 2023, selling an estimated $7.08M.
  • IEQ Capital's ten largest holdings make up 38% of its $4.96B portfolio in Q2 2023.
  • IEQ Capital opened 89 new positions and closed 81 in Q2 2023.
  • IEQ Capital's portfolio value rose 15% quarter-over-quarter to $4.96B.

Based on IEQ Capital's 13F filing for Q2 2023, filed 8 Aug 2023.